4 free views remaining today
Moyamoya disease
ICD-10 Codes
Related ICD-10:
Description
Moyamoya Disease: A Rare Cerebrovascular Disorder
Moyamoya disease is a rare and progressive condition that affects the blood vessels in the brain, leading to narrowing or blockage of the internal carotid arteries and their branches. This can result in reduced blood flow to the affected areas of the brain, potentially causing stroke, aneurysm, bleeding, or other complications.
Characteristics of Moyamoya Disease
- Progressive disorder: Moyamoya disease is a chronic condition that worsens over time if left untreated.
- Narrowing or blockage of blood vessels: The internal carotid arteries and their branches become narrowed or blocked, reducing blood flow to the brain.
- Collateral circulation formation: To compensate for the reduced blood flow, collateral vessels may form, which can appear as a "puff of smoke" on imaging tests (hence the name "moyamoya").
- Risk of stroke and bleeding: The narrowed or blocked blood vessels increase the risk of stroke, aneurysm, or bleeding in affected areas of the brain.
Causes and Risk Factors
While the exact cause of moyamoya disease is unknown, it is believed to be a genetic condition that can run in families. Other potential risk factors include:
- Genetic predisposition: Moyamoya disease may be inherited from one's parents.
- Age: The condition typically affects children and young adults.
References
- [1] (Result 2) describes moyamoya disease as a "rare, progressive cerebrovascular disorder caused by blocked arteries at the base of the brain."
- [3] states that moyamoya disease is a rare condition affecting the blood vessels in the brain.
- [5] explains that moyamoya is a rare condition where the internal carotid arteries become narrowed.
- [6] describes moyamoya disease as a progressive disorder affecting the blood vessels in the brain, characterized by narrowing and/or blockage of these vessels.
- [7] states that moyamoya disease affects the blood vessels in the brain, causing them to narrow or become blocked.
- [10] provides a detailed description of moyamoya disease, including its characteristics and risk factors.
Additional Characteristics
- Progressive disorder
- Narrowing or blockage of blood vessels
- Collateral circulation formation
- Risk of stroke and bleeding
Signs and Symptoms
Moyamoya disease is a rare cerebrovascular disorder that can cause various symptoms, which can be divided into two categories: sudden symptoms and recurring symptoms.
Sudden Symptoms
- Confusion [5]
- Difficulty speaking or understanding speech [5]
- Loss of coordination, including problems walking [5]
- Nausea or vomiting [5]
- Numbness or weakness in the face, arm, or leg [5]
These symptoms can occur suddenly and may be a sign of a stroke or other serious condition.
Recurring Symptoms
- Recurring transient ischemic attacks (TIAs or "mini-strokes") [6]
- Epilepsy [6]
- Stroke: Ischemic stroke (due to blockage) or hemorrhagic stroke (due to bleeding) [6]
- Headaches, visual disturbances, developmental delay, and seizures [7]
These symptoms can occur repeatedly and may be a sign of moyamoya disease.
Other Symptoms
- Fainting or blacking out [8]
- Loss of sight in one eye [8]
- Blurry vision [8]
- Poor vision in both eyes [8]
- Inability to recognize objects [8]
These symptoms can also occur and may be a sign of moyamoya disease.
It's worth noting that the symptoms of moyamoya disease can vary from person to person, and not everyone will experience all of these symptoms. If you or someone you know is experiencing any of these symptoms, it's essential to seek medical attention immediately.
References: [1] - Not available [2] - Not available [3] - Not available [4] - Not available [5] - Context 5: Sudden symptoms · Confusion · Difficulty speaking or understanding speech · Loss of coordination, including problems walking · Nausea or vomiting · Numbness or weakness in the face, arm, or leg · [6] - Context 6: Moyamoya Disease Symptoms · Recurring transient ischemic attacks (TIAs or “mini-strokes”) · Epilepsy · Stroke: Ischemic stroke (due to blockage) or hemorrhagic stroke (due to bleeding) [7] - Context 7: Other symptoms that may result include headaches, visual disturbances, developmental delay, and seizures. Approximately 10-30% of cases of moyamoya in Asian populations have been reported. [8] - Context 8: Symptoms · Fainting or blacking out · Loss of sight in one eye · Blurry vision · Poor vision in both eyes · Inability to recognize objects
Additional Symptoms
- Nausea or vomiting
- Blurry vision
- Epilepsy
- Inability to recognize objects
- Difficulty speaking or understanding speech
- Loss of coordination, including problems walking
- Numbness or weakness in the face, arm, or leg
- Recurring transient ischemic attacks (TIAs or 'mini-strokes')
- Stroke: Ischemic stroke (due to blockage) or hemorrhagic stroke (due to bleeding)
- Headaches, visual disturbances, developmental delay, and seizures
- Fainting or blacking out
- Loss of sight in one eye
- Poor vision in both eyes
- confusion
Diagnostic Tests
Moyamoya disease can be diagnosed through various tests, which help identify the narrowing or blockage of blood vessels in the brain.
- Cerebral Angiography: This is considered the criterion standard for diagnosing moyamoya disease. It involves inserting a catheter into a blood vessel in the groin and guiding it to the brain to take detailed images of the blood vessels [3]. The findings that support the diagnosis include stenosis or occlusion of the internal carotid artery, and the presence of moyamoya collaterals [3].
- Magnetic Resonance Imaging (MRI): MRI uses similar technology to take pictures inside your body and can help assess the effect of moyamoya disease on your brain. It may provide the first indications of the disease, but it is not as definitive as cerebral angiography [7][8].
- Computed Tomography (CT) scans: CT scans may also be used to diagnose moyamoya disease, particularly in emergency situations where a stroke or hemorrhage is suspected [7].
- Magnetic Resonance Angiography (MRA): MRA uses MRI technology to take detailed images of the blood vessels and can help identify the narrowing or blockage of blood vessels in the brain. It may be used as an alternative to cerebral angiography, but it is not as accurate [2].
- Other tests: In addition to these tests, a neurologist may also order other tests such as MRI/Nova and Xenon CT scans to help diagnose moyamoya disease [5].
It's worth noting that the diagnosis of moyamoya disease typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. A specialist will review your symptoms, medical history, and test results to make an accurate diagnosis.
References: [1] Not provided (context does not contain information about this number) [2] by S KURODA · 2022 · Cited by 131 [3] Apr 23, 2024 [4] Not provided (context does not contain information about this number) [5] Apr 18, 2023 [6] Not provided (context does not contain information about this number) [7] Apr 23, 2024 [8] Apr 23, 2024
Additional Diagnostic Tests
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT) scans
- Cerebral Angiography
- Magnetic Resonance Angiography (MRA)
- Nova and Xenon CT scans
Treatment
Overview of Drug Treatment for Moyamoya Disease
Moyamoya disease, a rare condition affecting the blood vessels in the brain, requires careful management to prevent complications such as strokes and bleeding. While surgery is often considered the preferred treatment option, drug therapy can be effective in managing symptoms and preventing further damage.
Medications Used in Moyamoya Disease Treatment
Several medications have been found to be beneficial in treating moyamoya disease:
- Aspirin: Aspirin can help prevent or reduce blood clots in the smaller, backup blood vessels that develop in moyamoya disease [1].
- Antiseizure medications: These medications can prevent seizures caused by moyamoya disease [2].
- Anticoagulants: Anticoagulants can thin the blood to prevent blood clots, but their use should be carefully considered due to the risk of bleeding [3].
- Blood thinners and calcium channel blockers: Certain drugs, including blood thinners and calcium channel blockers, may offer important benefits in managing moyamoya disease, such as reducing blood pressure and preventing blood vessel damage [4].
Goals of Drug Therapy
The primary goals of drug therapy for moyamoya disease are to:
- Prevent strokes: By managing blood pressure and preventing blood clots, drug therapy can help prevent strokes.
- Reduce symptoms: Medications can also help alleviate symptoms such as seizures and headaches.
Limitations of Drug Treatment
While drug therapy can be effective in managing moyamoya disease, it is essential to note that:
- No medication can stop the progression of the disease: Moyamoya disease will continue to progress over time, even with treatment [5].
- Surgery may still be necessary: In some cases, surgery may be required to reestablish blood supply to the brain.
References
[1] Context 2 [2] Context 2 [3] Context 8 [4] Context 4 [5] Context 7
Recommended Medications
- Anticoagulants
- Antiseizure medications
- Blood thinners and calcium channel blockers
- acetylsalicylic acid
- Aspirin
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Moyamoya disease is a rare disorder that affects the blood vessels in the brain, and its differential diagnosis involves considering various conditions that can present with similar symptoms.
Similar Cerebrovascular Lesions
According to [3], moyamoya disease shares similarities with other cerebrovascular lesions, including:
- Atherosclerosis: This condition involves the narrowing of arteries due to plaque buildup, which can lead to reduced blood flow to the brain.
- Phakomatoses: These are a group of rare genetic disorders that affect the development of blood vessels and can cause similar symptoms to moyamoya disease.
- Neurofibromatosis type 1 (NF1): This is a genetic disorder that affects the growth and development of nerve tissue, which can lead to abnormalities in blood vessel formation.
Other Conditions
In addition to these conditions, other differential diagnoses for moyamoya disease include:
- Cranial radiotherapy: Exposure to radiation therapy can cause damage to blood vessels in the brain.
- Infection: Certain infections, such as meningitis or encephalitis, can cause inflammation and damage to blood vessels in the brain.
- Tuberous sclerosis: This is a rare genetic disorder that affects multiple organ systems, including the brain, where it can cause abnormalities in blood vessel formation.
Key Differences
It's essential to note that moyamoya disease has distinct pathognomonic arteriographic findings bilaterally with no associated risk factors [4]. In contrast, other conditions may have different risk factors or present with different symptoms.
References: [3] Kuroda S. (2022) [4] By definition, people with moyamoya disease typically have the pathognomonic arteriographic findings bilaterally with no associated risk factors. [8] Zhang H. (2019)
Additional Differential Diagnoses
- cerebral atherosclerosis
- intracranial vasospasm
- Infection
- Phakomatoses
- Cranial radiotherapy
- neurofibromatosis 1
- tuberous sclerosis
- atherosclerosis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_8329
- owl#annotatedSource
- t403457
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- Xref MGI. OMIM mapping confirmed by DO. [SN].
- oboInOwl#id
- DOID:13099
- core#notation
- DOID:13099
- oboInOwl#hasDbXref
- UMLS_CUI:C0026654
- core#exactMatch
- MESH:D009072
- IAO_0000115
- A cerebral arterial disease characterized by constriction of certain arteries at the base of the brain. Blood flow is blocked by the constriction and also by blood clots.
- rdf-schema#label
- Moyamoya disease
- oboInOwl#hasExactSynonym
- progressive intracranial arterial occlusion
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_3527
- relatedICD
- http://example.org/icd10/I67.5
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.